Skip to main content
. Author manuscript; available in PMC: 2014 Mar 28.
Published in final edited form as: J Cardiovasc Pharmacol Ther. 2012 Nov 19;18(2):152–161. doi: 10.1177/1074248412458975

Figure 4. Cromolyn sodium reduces cardiac mast cell density and size, 28 days after EAM induction.

Figure 4

Representative sections of the heart treated with cromolyn sodium (a) or saline (b) using a monoclonal antibody to mast-cell tryptase (brown). Arrows indicate mast cells containing tryptase. Analysis based on average density and size shows that cromolyn sodium treatment significantly reduced cardiac mast cell density (c) and size (d).